|
ZNF681 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.713780E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.998400E-01 |
| Normal-vs-Stage2 |
1.257610E-01 |
| Normal-vs-Stage3 |
6.432000E-02 |
| Normal-vs-Stage4 |
9.337900E-03 |
| Stage1-vs-Stage2 |
2.763400E-01 |
| Stage1-vs-Stage3 |
1.042410E-01 |
| Stage1-vs-Stage4 |
9.275900E-03 |
| Stage2-vs-Stage3 |
9.988000E-01 |
| Stage2-vs-Stage4 |
3.207400E-01 |
| Stage3-vs-Stage4 |
2.424000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.202030E-01 |
| Normal-vs-AfricanAmerican |
6.334000E-01 |
| Normal-vs-Asian |
9.250200E-01 |
| Caucasian-vs-AfricanAmerican |
7.693800E-01 |
| Caucasian-vs-Asian |
1.100580E-01 |
| AfricanAmerican-vs-Asian |
5.914400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.815200E-01 |
| Normal-vs-Female |
1.633200E-01 |
| Male-vs-Female |
6.850800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.869800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.208450E-01 |
| Normal-vs-Age(61-80Yrs) |
1.383200E-01 |
| Normal-vs-Age(81-100Yrs) |
7.488400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.779380E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.024800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.308620E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.358200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.477200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.303000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.501960E-01 |
| Classical-VS-Follicular |
9.954800E-01 |
| Classical-VS-Other |
4.305200E-01 |
| Classical-VS-Normal |
2.634200E-01 |
| Tall-VS-Follicular |
2.006600E-01 |
| Tall-VS-Other |
2.628800E-01 |
| Tall-VS-Normal |
5.248200E-02 |
| Follicular-VS-Other |
2.603400E-01 |
| Follicular-VS-Normal |
4.109800E-01 |
| Other-VS-Normal |
5.887400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.290400E-01 |
| Normal-vs-N1 |
9.006300E-02 |
| N0-vs-N1 |
4.451800E-01 |
|
|
